A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was designed and synthesized. A 2,2-dimethyl-2,3-dihydrobenzofuran scaffold was investigated as a constrained variant of a biologically active isopropyl phenyl ether. Construction of the required dimethyl-2,3-dihydrobenzofuran intermediate began using a procedure that relied on a microwave-assisted alkylation reaction. The synthesis of the designed compound as its HCl salt is reported in a total of 12 steps and 17% overall yield. Biological evaluation revealed the constrained analog to be a selective serotonin 2C agonist with modest potency
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
We report here the design, synthesis, and pharmacological properties of a series of compounds relate...
A strategy to replace the ethylamine side chain of 2,5-dimethoxy-4- iodoamphetamine (DOI, 1a), and 2...
A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was de...
A new series of fluorinated 5-HT2C agonists were designed and synthesized on the basis of our previo...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
Two chemical probes (4, 5) for the agonist binding sites of serotonin 5-HT2A and 5-HT2C receptors we...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
A series of N-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the ...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
(Chemical Equation Presented) Treating neurological conditions: Optimization of a previously identif...
The 5-HT2C receptor is an attractive drug target in the quest for new therapeutics to treat a variet...
Efforts to understand better the serotonin-2A (5-HT2A) receptor were concentrated on the characteriz...
On the basis of the structural similarity of our previous 5-HT2C agonists with the melatonin recepto...
Novel and potent ligands to the serotonin7 (5-HT7) receptor have been synthesized. The synthesized ...
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
We report here the design, synthesis, and pharmacological properties of a series of compounds relate...
A strategy to replace the ethylamine side chain of 2,5-dimethoxy-4- iodoamphetamine (DOI, 1a), and 2...
A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was de...
A new series of fluorinated 5-HT2C agonists were designed and synthesized on the basis of our previo...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
Two chemical probes (4, 5) for the agonist binding sites of serotonin 5-HT2A and 5-HT2C receptors we...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
A series of N-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the ...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
(Chemical Equation Presented) Treating neurological conditions: Optimization of a previously identif...
The 5-HT2C receptor is an attractive drug target in the quest for new therapeutics to treat a variet...
Efforts to understand better the serotonin-2A (5-HT2A) receptor were concentrated on the characteriz...
On the basis of the structural similarity of our previous 5-HT2C agonists with the melatonin recepto...
Novel and potent ligands to the serotonin7 (5-HT7) receptor have been synthesized. The synthesized ...
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
We report here the design, synthesis, and pharmacological properties of a series of compounds relate...
A strategy to replace the ethylamine side chain of 2,5-dimethoxy-4- iodoamphetamine (DOI, 1a), and 2...